Definitive Contract HHSN272201300029C

Research and Diagnostic Systems, Inc. (R&D Systems), a Minneapolis-based manufacturer of biological research materials and subsidiary of Bio-Techne Corporation, was awarded a Blanket Purchase Agreement (BPA) call valued at $3,201.80 by the National Institute of Neurological Disorders and Stroke (NINDS) on February 4, 2013, with an ultimate completion date of August 31, 2013. The contract utilized firm fixed pricing and was not designated as a set-aside purchase, indicating open...

Research and Diagnostic Systems, Inc. (R&D Systems), a Minneapolis-based subsidiary of Bio-Techne Corporation, was awarded a firm fixed price call under its existing Blanket Purchase Agreement (BPA) with the National Center for Advancing Translational Sciences (NCATS) on May 20, 2015. The contract, valued at $13,204, is for the provision of recombinant human ubiquitin rhodamine 110 conjugate in a custom size of four 1-milligram units. This award was made without a set-aside designation,...

Research and Diagnostic Systems, Inc. (R&D Systems), a Minneapolis-based subsidiary of Bio-Techne Corporation, was awarded a $21,418.90 firm fixed-price call against a Blanket Purchase Agreement (BPA) by the National Center for Advancing Translational Sciences on June 24, 2014. The contract covers the supply of a custom TrocrIScreen compound library consisting of 594 compounds at 5 milligrams each, to be delivered by August 31, 2014. This award was made through open competition with no...

The National Institute on Drug Abuse (NIDA) has awarded a definitive cost-plus-no-fee contract valued at $30.3M to the University of Maryland, Baltimore to establish and operate the NIH NeuroBioBank Brain and Tissue Repository (NBB), a collection site that will acquire, process, store, curate, preserve, and distribute central nervous system (CNS) and related tissue samples for neurological, psychiatric, and neurodevelopmental disorder research. The contract, which carries no set-aside...

Research and Diagnostic Systems, Inc. (R&D Systems), a Minneapolis-based manufacturer of biological research materials and subsidiary of Bio-Techne Corporation, was awarded a $14,160 firm fixed-price blanket purchase agreement (BPA) call by the National Institute on Aging on August 5, 2011, with an ultimate completion date of August 31, 2011. The contract, which involved no set-aside designation, covers the procurement of research and diagnostic systems and ELISA kits to support the agency's...

This federal contract award was made by the National Heart Lung and Blood Institute, a civilian agency within the National Institutes of Health (NIH), to Research And Diagnostic Systems, Inc. (R&D Systems), a subsidiary of Bio-Techne Corporation. The $13,785.00 firm fixed-price contract is for the delivery of vital research panels to support the agency's research on the effect of pain crisis and cytokines. The contract does not have a set-aside designation. R&D Systems is a...

Research and Diagnostic Systems, Inc. (R&D Systems), a subsidiary of Bio-Techne Corporation headquartered in Minneapolis, Minnesota, received a $14,160 firm fixed price Blanket Purchase Agreement (BPA) call award from the National Institute on Aging on July 23, 2012, with an ultimate completion date of July 31, 2012. This non-set-aside contract was awarded through open competition and represents a task order under R&D Systems' existing BPA for the provision of biological research...

This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Research And Diagnostic Systems, Inc. (R&D Systems), a manufacturer of high quality antibodies, ELISA kits, proteins, and assays. The $681,088.00 contract is for the supply of assorted proteins and small molecules. R&D Systems, a division of the parent company Bio-Techne Corporation, has provided a range of...

Research and Diagnostic Systems, Inc. (R&D Systems), a Minneapolis-based subsidiary of Bio-Techne Corporation, was awarded a $6,974.05 firm fixed-price call under a Blanket Purchase Agreement (BPA) by the National Heart, Lung, and Blood Institute (NHLBI) on March 11, 2016. The contract, which utilized no set-aside designation and operated under open competition, was for the supply of recombinant human/mouse/rat Activin A protein, a bioactive reagent commonly used in cardiovascular and...

This is a $4,921,543.00 cost-reimbursement contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency, to Biomedical Research Models, Inc. on July 27, 2006. The contract is for biomedical research and development and does not have a set-aside designation. The period of performance runs through July 13, 2012. Biomedical Research Models, Inc. is a for-profit organization registered in the System for Award Management (SAM) with an expiration date...